Lamisil and Urination - excessive volume - a phase IV clinical study of FDA data

Summary:

Urination - excessive volume is reported as a side effect among people who take Lamisil (terbinafine hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Protonix, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Urination - excessive volume when taking Lamisil. It is created by eHealthMe based on reports of 13,455 people who have side effects when taking Lamisil from the FDA, and is updated regularly.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.

What is Urination - excessive volume?

Urination - excessive volume is found to be associated with 970 drugs and 1,294 conditions by eHealthMe. Check the latest studies of Urination - excessive volume.

On Sep, 24, 2025

13,455 people reported to have side effects when taking Lamisil.
Among them, 11 people (0.08%) have Urination - excessive volume.

Could Lamisil cause Urination - excessive volume?

Among these 11 people:

How long have people been on Lamisil when they have Urination - excessive volume? *

What is the gender of people who have Urination - excessive volume when taking Lamisil? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Urination - excessive volume when taking Lamisil? *

What are other drugs people take besides Lamisil? *

What are other side effects people have besides Urination - excessive volume? *

Pain: 8 people, 72.73%
Dyspnea (difficult or laboured breathing): 8 people, 72.73%
Oedema Peripheral (superficial swelling): 7 people, 63.64%
Nausea (feeling of having an urge to vomit): 7 people, 63.64%
Fever: 7 people, 63.64%
Gait Disturbance: 6 people, 54.55%
Eyelid Ptosis (falling of the upper or lower eyelid): 6 people, 54.55%
High Blood Pressure: 6 people, 54.55%
Nosebleed (bleeding from nose): 6 people, 54.55%
Neck Pain: 6 people, 54.55%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 54.55%
Upper-Airway Cough Syndrome: 2 people, 18.18%
Oedema Peripheral (superficial swelling): 2 people, 18.18%
Cough: 2 people, 18.18%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 18.18%
Asthma: 2 people, 18.18%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 18.18%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 18.18%
Stress And Anxiety: 2 people, 18.18%
Pain: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lamisil and have Urination - excessive volume?

- Check whether Urination - excessive volume is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamisil:

Lamisil (14,080 reports)

Browse all side effects of Lamisil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urination - excessive volume:

Urination - excessive volume (970 drugs)

Browse all the conditions that are associated with Urination - excessive volume:

Urination - excessive volume (1,294 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on terbinafine hydrochloride (the active ingredients of Lamisil) and Lamisil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.